Protagenic Therapeutics(PTIX) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Ticker symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 PTIX Nasdaq Capital Market Common Stock Purchase Warrant PTIXW Nasdaq Capital Market Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging Growth Company ☐ FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the q ...